Select Advisor Llc Venbio serves as Executive at Mirati Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Select Advisor Llc Venbio has executed 5 insider transactions totaling $27.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 15, 2018 involved purchasing 200,000 shares valued at $4.7M.
Select Advisor Llc Venbio currently holds 17,714,461 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Select Advisor Llc Venbio has been a net buyer of MRTX stock. They have purchased $27.0M and sold $0 worth of shares.
Select Advisor Llc Venbio's most recent insider trade was on Jun 15, 2018, when they purchased 200,000 shares at $23.39 per share.
Get notified when new Form 4 filings are submitted
| $7.86 |
| Discretionary |
| Nov 16, 2017 | MRTX | $8.4M | Purchase | 650,000 | $13.00 | Discretionary |
| Nov 15, 2017 | IMMU | $1.9M | Purchase | 175,000 | $10.97 | Discretionary |
| Nov 14, 2017 | IMMU | $11.9M | Purchase | 1,150,000 | $10.39 | Discretionary |